Sveriges mest populära poddar
Docs Who Lift
Docs Who Lift

Zepbound - Tirzepatide for obesity approval

23 min•10 november 2023

Om avsnittet

Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity.

Learn:

  1. When will it be available
  2. How much will is cost
  3. Any differences compared to Mounjaro
  4. Surmount 3 trial



Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fler avsnitt

Visa alla avsnitt av Docs Who Lift

Food Noise Is Real, and Now We Can Measure It

49 min

Does Metabolically Healthy Obesity Even Exist?

48 min

Is Your Obesity Genetic? Food Noise and Bardet-Biedl Syndrome Explained

40 min

PCOS Renamed to PMOS? Here's Why and What Changes for You

37 min

Are Peptides the New Snake Oil? What the Actual Science Says With Barbell Medicine

57 min

Retatrutide Phase 3 Results: What the Data Actually Means

45 min

GLP-1 Maintenance: What Happens When You Lower Your Dose, Switch Medications, or Stop Entirely

40 min

Are GLP-1 Medicines Shredding Your Bones? Here Is What the Actual Evidence Says With Dr. Susan Brian

32 min

Heavy Metal Toxicity: Separating Real Risks From Influencer Scams | Dr. Eryn Russo

53 min

GLP-1 Genetics: Predicting Weight Loss and Side Effects With 23andMe's Dr. Adam Auton

25 min

Docs Who Lift med Docs Who Lift finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.